Showing results (151-160 of 629) with videos related to

Sort By:
Pageof 63
Reviews in Cardiovascular Medicine|July 30, 2024
P2Y12 Inhibitor Monotherapy: Considerations for Acute and Long-Term Secondary Prevention Post-PCIAntonio Greco, Maria Sara Mauro, Davide Capodanno, et al.
Diabetes & Vascular Disease Research|October 6, 2010
Platelet abnormalities in diabetes mellitusJosé Luis Ferreiro, Joan Antoni Gómez-Hospital, Dominick J Angiolillo
Expert Opinion on Pharmacotherapy|October 22, 2008
Prasugrel: a novel platelet ADP P2Y12 receptor antagonist. A review on its mechanism of action and clinical developmentDominick J Angiolillo, Siva Suryadevara, Piera Capranzano, et al.
Expert Opinion on Drug Safety|November 6, 2025
Long-term safety of oral antiplatelet strategies for patients with acute coronary syndrome undergoing percutaneous coronary interventionClaudio Laudani, Luis Ortega-Paz, Davide Capodanno, et al.
Journal of the American Heart Association|November 24, 2020
Coronavirus Disease 2019-Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic ManagementLuis Ortega-Paz, Davide Capodanno, Gilles Montalescot, et al.
JACC. Cardiovascular Interventions|August 5, 2019
Effects of Methylnaltrexone on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients Treated With MorphineFrancesco Franchi, Fabiana Rollini, Yongwhi Park, et al.
Revista Espanola De Cardiologia|May 21, 2004
[Inflammation in acute coronary syndromes: mechanisms and clinical implications]Dominick J Angiolillo, Luigi M Biasucci, Giovanna Liuzzo, et al.
Expert Opinion on Investigational Drugs|November 1, 2018
CSL112, a reconstituted, infusible, plasma-derived apolipoprotein A-I: safety and tolerability profiles and implications for management in patients with myocardial infarctionDavide Capodanno, Roxana Mehran, C Michael Gibson, et al.
Journal of Thrombosis and Thrombolysis|December 26, 2013
Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studiesDominick J Angiolillo, Catherine Datto, Shane Raines, et al.
Thrombosis and Haemostasis|June 29, 2020
Dual Pathway Inhibition for Vascular Protection in Patients with Atherosclerotic Disease: Rationale and Review of the EvidenceJeffrey Ian Weitz, Dominick J Angiolillo, Tobias Geisler, et al.
Pageof 63